SCHEDULE: aMoon Funds Sell SOPHiA GENETICS Shares

aMoon Edge Limited Partnership has sold 192,541 Ordinary Shares of SOPHiA GENETICS SA in a private transaction.

Summary

• This filing is an amendment to a Schedule 13D, reporting changes in beneficial ownership of SOPHiA GENETICS SA.
• The primary event reported is the sale of 192,541 Ordinary Shares by aMoon Edge Limited Partnership.
• The sale occurred on November 10, 2026, in a private block sale.
• The shares were sold at a price of $7.70 per share.
• The total gross proceeds from this sale were approximately $1.48 million.
• Following this transaction, aMoon Growth holds 5,318,023 Ordinary Shares, representing 6.2% of the issued and outstanding shares.
• The filing details the reporting persons' relationships and their beneficial ownership claims.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as neutral to slightly negative, as it primarily reports a sale of shares rather than new strategic initiatives or positive financial performance.

Positives

• The sale was conducted in a private block transaction, potentially indicating a controlled sale process.
• The sale generated approximately $1.48 million in gross proceeds.

Negatives

• A significant number of shares were sold by a reporting entity, indicating a reduction in stake.
• The sale was a private transaction, which may not reflect broader market sentiment or valuation.

Risks

• The sale of shares by a significant holder could be interpreted as a lack of confidence in future share price appreciation.
• The exact reasons for the sale are not detailed, leaving room for speculation about underlying concerns.

Future Outlook

The filing does not contain specific forward-looking statements or guidance from the company regarding future performance. It solely reports a past transaction by a reporting person.

Industry Context

StockSavvy.ai notes that Schedule 13D filings typically report significant changes in beneficial ownership. This particular amendment indicates a reduction in stake by aMoon Edge, which could be a signal to the market, though the reasons are not disclosed.

Stakeholder Impact

• Shareholders may view the sale by a significant holder as a potential negative signal, possibly impacting share price.
• The reduction in stake by aMoon Edge could lead to a shift in the balance of influence among major shareholders.

Next Steps

• The reporting persons will continue to monitor the Issuer's business and may, from time to time, acquire or dispose of additional securities of the Issuer.

Key Dates

Recommendation

The filing reports a share sale by a significant holder, which is a neutral to slightly negative event. It does not provide new strategic information or financial performance data for SOPHiA GENETICS SA itself. Therefore, a 'hold' recommendation is appropriate, pending further company disclosures or market developments.

Keywords

SOPHiA GENETICS, Schedule 13D, aMoon Growth Fund, aMoon Edge, Ordinary Shares, Block Sale, Beneficial Ownership, Shareholder